BeOne Medicines Ltd. (SHA:688235)

BeOne Medicines Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,756	2,627	3,172	3,870	4,376	1,382
Short-Term Investments	-	-	-	665.25	2,245	3,269
Cash & Short-Term Investments	2,756	2,627	3,172	4,535	6,621	4,651
Cash Growth	6.30%	-17.16%	-30.06%	-31.50%	42.36%	373.24%
Accounts Receivable	770.78	676.28	358.03	173.17	483.11	60.4
Other Receivables	-	32.83	37.86	25.82	17.06	19.27
Receivables	770.78	709.11	395.89	198.98	500.18	79.67
Inventory	502.87	494.99	416.12	282.35	242.63	89.29
Prepaid Expenses	280.52	49.37	88.26	83.09	138.81	57.74
Restricted Cash	-	9.31	11.47	0.2	0.33	0.31
Other Current Assets	-	101.41	119.88	107.65	111.32	83.01
Total Current Assets	4,310	3,992	4,203	5,207	7,614	4,961
Property, Plant & Equipment	1,762	1,718	1,419	955.91	705.04	448.27
Long-Term Investments	-	128.93	89.64	91.78	100.79	49.34
Goodwill	-	-	-	-	0.11	0.11
Other Intangible Assets	64.89	51.1	57.14	40.62	46.68	5
Long-Term Deferred Tax Assets	-	-	-	-	-	65.96
Other Long-Term Assets	161.72	31.56	35.72	83.91	69.03	71.39
Total Assets	6,298	5,921	5,805	6,379	8,536	5,601
Accounts Payable	360.78	405	315.11	294.78	262.4	231.96
Accrued Expenses	1,018	780.48	624.92	480.1	534.33	389.75
Short-Term Debt	808.39	816.95	659.79	314.83	424.74	334.71
Current Portion of Long-Term Debt	-	34.58	28.58	14.14	2.82	0.31
Current Portion of Leases	17.25	17.58	21.95	24.04	21.93	13.9
Current Income Taxes Payable	5.54	25.93	22.95	25.19	21.4	20.38
Current Unearned Revenue	-	-	-	213.86	187.41	-
Other Current Liabilities	-	134.39	136.82	101.59	144.53	84.2
Total Current Liabilities	2,210	2,215	1,810	1,469	1,600	1,075
Long-Term Debt	146.09	166.48	197.62	209.15	202.11	183.64
Long-Term Leases	53.94	44.28	22.25	34.52	43.04	29.42
Long-Term Unearned Revenue	-	30.32	34.2	80.2	266.64	49.14
Long-Term Deferred Tax Liabilities	44.09	42.01	16.49	16	14.17	10.79
Other Long-Term Liabilities	73.96	74.29	172.27	179.78	269.63	375.22
Total Liabilities	2,528	2,589	2,268	1,996	2,403	1,732
Common Stock	0.14	0.14	0.14	0.14	0.13	0.12
Additional Paid-In Capital	12,395	12,088	11,599	11,541	11,191	7,415
Retained Earnings	-8,511	-8,607	-7,962	-7,080	-5,077	-3,553
Comprehensive Income & Other	-113.7	-148.99	-99.45	-77.42	17.95	6.94
Total Common Equity	3,770	3,332	3,537	4,383	6,133	3,869
Shareholders' Equity	3,770	3,332	3,537	4,383	6,133	3,869
Total Liabilities & Equity	6,298	5,921	5,805	6,379	8,536	5,601
Total Debt	1,026	1,080	930.19	596.68	694.64	561.96
Net Cash (Debt)	1,730	1,548	2,242	3,938	5,926	4,089
Net Cash Growth	15.15%	-30.96%	-43.08%	-33.54%	44.94%	479.63%
Net Cash Per Share	16.19	14.70	21.47	38.19	63.87	48.98
Filing Date Shares Outstanding	109.86	106.72	104.58	104.32	102.68	91.6
Total Common Shares Outstanding	109.86	106.72	104.58	104.32	102.68	91.6
Working Capital	2,100	1,777	2,393	3,739	6,014	3,885
Book Value Per Share	34.32	31.22	33.82	42.02	59.73	42.24
Tangible Book Value	3,706	3,281	3,480	4,343	6,086	3,864
Tangible Book Value Per Share	33.73	30.75	33.28	41.63	59.27	42.18
Land	-	65.49	65.49	65.49	65.49	-
Buildings	-	607.86	231.66	222.45	144.08	111.53
Machinery	-	485.14	392.21	334.59	237.79	175.31
Construction In Progress	-	654.02	740.62	293.63	186.84	85.78
Leasehold Improvements	-	64.68	60.12	53.79	50.29	37.64

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.